Cargando…

Insulin-Like Growth Factor Binding Proteins-3 and -5: Central Mediators of Fibrosis and Promising New Therapeutic Targets

Fibrosis involves an orchestrated cascade of events including activation of fibroblasts, increased production and deposition of extracellular matrix components, and differentiation of fibroblasts into myofibroblasts. Epithelial-mesenchymal cross-talk plays an important role in this process, and curr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veraldi, Kristen L, Feghali-Bostwick, Carol A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395973/ https://www.ncbi.nlm.nih.gov/pubmed/22802912 http://dx.doi.org/10.2174/1874312901206010140

Ejemplares similares

Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
por: Garrett, Sara M., et al.
Publicado: (2019)

Syndecan-2 Is a Novel Target of Insulin-Like Growth Factor Binding Protein-3 and Is Over-Expressed in Fibrosis
por: Ruiz, Ximena D., et al.
Publicado: (2012)

Human Skin Culture as an Ex Vivo Model for Assessing the Fibrotic Effects of Insulin-Like Growth Factor Binding Proteins
por: Yasuoka, Hidekata, et al.
Publicado: (2008)

Fibroblasts in fibrosis: novel roles and mediators
por: Kendall, Ryan T., et al.
Publicado: (2014)

Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2021)

Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4
por: Su, YunYun, et al.
Publicado: (2019)

IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2018)

IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF
por: Su, Yunyun, et al.
Publicado: (2015)

The Membrane-Associated Adaptor Protein DOK5 Is Upregulated in Systemic Sclerosis and Associated with IGFBP-5-Induced Fibrosis
por: Yasuoka, Hidekata, et al.
Publicado: (2014)

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
por: Mouawad, Joe E., et al.
Publicado: (2023)

Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5
por: Yamaguchi, Yukie, et al.
Publicado: (2011)

382 The Role of the IL-6-IGF-II Axis in Systemic Sclerosis-Associated Lung Fibrosis
por: Adewale, Adegboyega Timothy, et al.
Publicado: (2023)

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
por: Coward, William R., et al.
Publicado: (2014)

The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis
por: Waldrep, Kristy M., et al.
Publicado: (2023)

Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis
por: Artlett, Carol M., et al.
Publicado: (2017)

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
por: Argula, Rahul G, et al.
Publicado: (2019)

Elucidating the cellular mechanism for E2-induced dermal fibrosis
por: Baker Frost, DeAnna, et al.
Publicado: (2021)

Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2020)

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K(Ca)3.1-dependent
por: Roach, Katy M, et al.
Publicado: (2014)

Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
por: Renaud, Ludivine, et al.
Publicado: (2020)

The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy Morgan, et al.
Publicado: (2013)

Correction: The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy M, et al.
Publicado: (2014)

Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury
por: Slavin, Benjamin R., et al.
Publicado: (2021)

PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
por: Takamura, Naoko, et al.
Publicado: (2021)

2027 The role of lysyl oxidase in systemic sclerosis-associated lung fibrosis
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2018)

A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition
por: Watanabe, Tomoya, et al.
Publicado: (2019)

Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease
por: Duan, Cunming, et al.
Publicado: (2020)

Induction of a Th17 Phenotype in Human Skin—A Mimic of Dermal Inflammatory Diseases
por: Garrett, Sara M., et al.
Publicado: (2019)

Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism
Publicado: (1996)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Corrigendum: Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease
por: Duan, Cunming, et al.
Publicado: (2020)

Insulin-like growth factor binding protein 5: Diverse roles in cancer
por: Waters, Jennifer A., et al.
Publicado: (2022)

Genetics of systemic sclerosis: recent advances
por: Ramos, Paula S., et al.
Publicado: (2015)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
por: Wang, Xiao Mei, et al.
Publicado: (2006)

Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis
por: Hadjicharalambous, Marina R., et al.
Publicado: (2019)

Insulin-like Growth Factor-2 (IGF-2) in Fibrosis
por: Zhu, Yuhan, et al.
Publicado: (2022)

The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
por: Haywood, Natalie J., et al.
Publicado: (2018)

Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts
por: Hadjicharalambous, Marina R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ba7u44l0spfuluh6e0n5tjrkc9